首页|以G-四链体为靶标的小分子抗病毒药物的研究进展

以G-四链体为靶标的小分子抗病毒药物的研究进展

扫码查看
G-四链体(G-quadruplexes,G4s)是由富含串联重复鸟嘌呤(Guanine,G)的DNA或RNA折叠形成的核酸二级结构,广泛存在于所有生物的基因组中,参与调控基因的复制、转录和翻译等多种过程.G4s因其关键的生物学作用而引起人们的兴趣,前期人们主要关注于G4s在癌症中的研究并将其作为抗肿瘤药物的靶点.最近,对病毒基因组学的研究发现许多G4s出现在病毒基因组的调节区,对调节病毒生命周期发挥关键作用.随着新病毒的出现和现有病毒的快速突变,需要开发新的抗病毒靶标和药物.目前现有的大多数抗病毒药物是以病毒的蛋白质为靶标,直接靶向病毒核酸的研究较少.以G4s为靶标的小分子配体的开发有助于帮助理解G4s介导的机制在病毒生命周期中的重要作用,也是一种新的抗病毒药物开发策略.通过对以G4s为靶标的小分子配体在抗病毒中的应用进行总结,旨在为基于G4s的抗病毒药物研发提供参考.
Research Progress of Small Molecular Antiviral Drugs Targeting G-quadruplex
G-quadruplexes(G4s)is a secondary structure of nucleic acid formed by the folding of DNA or RNA rich in tandem repeat guanine(G).It widely exists in the genomes of all organisms and participates in the regulation of gene replication,transcription and translation.G4s has aroused interest from researchers because of its key biological functions.In the early days,researchers mainly focused on the study of G4s in cancer and used it as the target of antineoplastic drugs.Recently,research on viral genomics has found that many G4s appear in the regulatory regions of the viral genome and play a key role in regulating the life cycle of the virus.With the emergence of new viruses in the human population and the rapid mutation of existing viruses,it is necessary to develop new antiviral targets and drugs.Most of the existing antiviral drugs aim mainly at viral proteins,with few studies on direct nucleic acid targeting.This paper summarizes the application of small molecular ligands targeting G4s against virus in order to provide some reference for the research and development of antiviral drugs based on G4s.

G-quadruplexantiviraltargetsmall molecular ligand

何兴瑞、刘梦婷、王子桉、贾译程、叶向阳、谢恬

展开 >

杭州师范大学药学院,浙江省榄香烯类抗癌中药重点实验室,浙产中药材资源开发与应用浙江省工程实验室,浙江省浙八味等浙产中药材综合利用开发2011协同创新中心,浙江 杭州 311121

G-四链体 抗病毒 靶标 小分子配体

2024

药学进展
中国药科大学

药学进展

影响因子:0.624
ISSN:1001-5094
年,卷(期):2024.48(9)